Search Results 111-120 of 14932 for HCG

  1. A Phase II, Multicenter Study Of The EZH2 Inhibitor Tazemetostat In Adult Subjects With INI1-Negative Tumors Or Relapsed/Refractory Synovial Sarcoma - Mayo Clinic

    Have a negative beta-human chorionic gonadotropin (β-hCG) pregnancy test at time of screening and within 14 days prior to planned first dose of tazemetostat ...

  2. Digestive Diseases Clinical Trials - Medical Professionals - Mayo Clinic

    Find gastroenterology, hepatology and digestive disease clinical trials at your nearest Mayo Clinic location.

  3. Impact Of CardiolRx On Myocardial Recovery In Acute Myocarditis - Mayo Clinic

    The minimum sensitivity of the pregnancy test must be 25 IU/L or equivalent units of HCG. WOCBP include any female who has experienced menarche and who has ...

  4. A Study To Assess Adult Allogeneic Expanded Adipose-derived Stem Cells (EASC) For The Treatment Of Complex Perianal Fistula(s) In Patients With Crohn's Disease - Mayo Clinic

    Women of childbearing potential (WCBP) must have negative serum pregnancy test at screening (sensitive to 25 IU human chorionic gonadotropin [hCG]). Both ...

  5. A Trial of 18F-AV-133 Positron Emission Tomography (PET) Imaging to Differentiate Subjects with Parkinson's Disease (PD) from other Movement Disorders - Mayo Clinic

    Females must not be pregnant (negative serum beta-hCG at the time of screening and negative urine beta-hCG on the day of imaging), must not be breastfeeding ...

  6. Hematology - Clinical trials

    Romidepsin and lenalidomide may stop the growth of cancer cells by blocking enzymes needed for cell growth. Giving rituximab together with romidepsin and ...

  7. Study Of RSIFN-co For Patients With Advanced Solid Tumors - Mayo Clinic

    ... HCG with a sensitivity of 50 mIU/ml pregnancy test within 7 days of study treatment) or breast-feeding; A medically acceptable method of birth control must ...

  8. Patient Stories - Glenn G. G. Shi, M.D. - Mayo Clinic

    Join the fight against cancer! ... Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated. Give Now.

  9. Analytic Treatment Interruption (ATI) to Assess HIV Cure - Mayo Clinic

    Negative serum β-HCG pregnancy test in women with childbearing potential; Have the ability to give appropriate informed consent. Exclusion Criteria. Women who ...

  10. A Study Of Icotrokinra In Participants With Moderately To Severely Active Crohn's Disease - Mayo Clinic

    A female participant of childbearing potential must have a negative highly sensitive serum pregnancy test (beta-hCG) at screening and a negative urine ...